pharmaphorum

MAY 31, 2022

billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate that is aiming to break into a market that for years has been dominated by Pfizer’s Prevnar franchise. The post GSK bolsters vaccines division with $3.3bn swoop on Affinivax appeared first on. GlaxoSmithKline has agreed a $3.3

Vaccines 52

Vaccines Immunization FDA 52

European Pharmaceutical Review

OCTOBER 24, 2022

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 91

European Pharmaceutical Review

OCTOBER 21, 2022

Clinical trial results presented at the US IDWeek conference, revealed a three-dose series of the HEPLISAV-B vaccine prevents hepatitis B virus (HBV) in HIV patients not previously vaccinated against or infected with the virus. At week 28, the study assessed the vaccine’s safety and levels of anti-HBV surface antibodies (HBsAbs).

Vaccines 96

Vaccines Immunization FDA 96

STAT

OCTOBER 27, 2022

The investigation began in February and covers 2017, 2018, and 2019. The Italian branch allegedly sent the capital to foreign affiliates linked to a units based in Delaware called Pfizer Production and Pfizer Manufacturing. Continue to STAT+ to read the full story…

Packaging 98

Packaging FDA Vaccines 98

IDStewardship

JULY 27, 2022

In 2017 I volunteered as a disaster relief pharmacist for a non-governmental organization. I worked in Sierra Leone for four months at an Ebola treatment centre, followed by a brief time in Nepal after the 2017 earthquake. In hospitals, there is a target to reduce WHO watch and reserve antibiotics by 10% compared to 2017 levels.

Hospitals 147

Hospitals Clinic Management Labelling Vaccines 147

pharmaphorum

MARCH 2, 2022

Pfizer’s vaccine for Clostridium difficile (C. Top-line efficacy for the vaccine was 49% at 12 months, 47% at 24 months and 31% at final analysis, said the drugmaker, which was forced to carry out the assessment after 42 cases of CDI, fewer than the 66 cases laid out in the trial protocol. With no approved vaccines to date, C.

Vaccines 52

Vaccines Hospitals FDA 52

pharmaphorum

JULY 30, 2021

Takeda has decided development of its norovirus vaccine candidate outside Japan will be more efficient if it is spun out into a dedicated company. The post Takeda spins norovirus vaccine out into separate company appeared first on. In 2019, it agreed a $170 million deal to buy back into the company’s platform.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

MARCH 27, 2023

The research includes historic market data from 2017 to 2021, using 2022 as the base year. million in 2017 and continued to grow until 2021. It covers various testing methods such as growth-based, nucleic-acid-based and viability-based. The segment was valued at $1,492.53

Compounding 115

Compounding Vaccines 115

European Pharmaceutical Review

MAY 2, 2024

“The scale and speed of impact seen after Beyfortus’ introduction demonstrates the strength of all-infant immunisation strategies against RSV in babies,” summarised Thomas Triomphe , Executive Vice President, Vaccines, Sanofi.

Hospitals 122

Hospitals Immunization Vaccines 122

European Pharmaceutical Review

DECEMBER 12, 2023

The progress of the RNA technology and tumour specific vaccination will be also key to increase adaptive immunity against the tumour but also as it participates to the activation of the innate immunity through RNA sensing. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

OCTOBER 26, 2020

Strategies include different options focused on health maintenance, such as vaccination programmes, smoking cessation services, support for physical activity, and access to technologies that support early detection of diseases. Figure 1: OECD average of public spending on health (Source: OECD ). per person in the US) and is widely adopted.

Vaccines 130

Vaccines 130

pharmaphorum

JULY 14, 2021

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.”

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

The Checkup by Singlecare

APRIL 3, 2024

According to a 2017 study , the beverage acts in an anti-inflammatory manner on different components of the immune system, such as natural killer (NK) cells, monocytes, and neutrophils. Keep up-to-date on vaccines as recommended by your provider. These medications may interfere with prednisone.

Immunization 105

Immunization Specialty Pharmacies Dosage Labelling 105

ISPE

OCTOBER 25, 2022

Throughout her early career, she successfully led multiple biotech, vaccine, and API processes from late-stage research and development to clinical and commercial manufacturing. She also worked on design and CQV projects of all sizes and provided business solutions to spearhead expansion of NNE and ADVENT.

Vaccines 98

Vaccines 98

The Checkup by Singlecare

JULY 11, 2024

Prednisolone ( Prednisolone is the active form, whereas prednisone has to be converted to prednisolone by the liver before it can work) , a powerful anti-inflammatory medication, has been shown effective as a first-line treatment for gout in studies such as those from 2016 and 2017. It might work quickly, too.

Dosage 94

Dosage Packaging Immunization FDA 94

pharmaphorum

SEPTEMBER 8, 2020

When the day hopefully comes where a vaccine is widely available, we will be relieved of the great stress and uncertainty of this time. 2017;(13):47-64. Available at [link] [Last accessed: September 2020]. 10 Wait S, Han D, Muthu V, et al. Journal of Cancer Policy.

Chemotherapy 98

Chemotherapy Patient Care Vaccines FDA 98

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Kite became an integral part of Gilead Sciences following its acquisition in 2017 by Gilead Sciences.

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

pharmaphorum

JUNE 15, 2021

New Science is projected to drive 81% of biopharma revenue growth and 61% of all revenues between 2021 and 2026, outpacing our previous forecast of 54% of all revenues from 2017-2022. Indeed, we estimate that 76% of all new deals intended to create new therapies in the past five years involved New Science treatments.

Vaccines 90

Vaccines 90

pharmaphorum

NOVEMBER 27, 2022

For example, many vaccines – including the COVID-19 one – must be kept refrigerated at a specific temperature throughout their journey, and if this isn’t communicated, it can render a whole batch unusable. Mix ups in hand-offs are another large disruptor, especially when drugs have specific shipping requirements.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

AUGUST 31, 2022

It seems the FDA is trying to get ahead of any scepticism about gene therapies that proved complicated when encouraging uptake of COVID-19 vaccines. The information provided gives a general background on the development of gene therapies, how they function in the body and how they are delivered. A broadening pipeline. billion in 2021.

FDA 98

FDA Compounding Vaccines 98

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 Seroquel IR’s patent expired in 2012, while Seroquel XR’s expired in 2017. The AZD1222 vaccine was invented by the University of Oxford and its spin-out company Vaccitech, then later licensed by AZ.

Pharmaceutical Companies 116

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 116

The Checkup by Singlecare

FEBRUARY 15, 2024

Since January 2017, Willy (a golden retriever) has been Madison’s constant companion. It will also help you consider various treatment options alongside a service animal. How service animals can help Service animals play vital roles in assisting individuals with disabilities. Take Madison and her diabetic-alert dog , Willy.

Health and Personal Care Stores 98

Health and Personal Care Stores Documentation Grocery Stores Hospitals 98

pharmaphorum

MAY 20, 2022

In recent years the retail pharmacy chain has begun to delve more and more deeply into the healthcare sector – by constantly expanding the basic healthcare services offered at their instore Minute Clinics, and by buying into the health insurance insurance space with their $69 billion purchase of Aetna in 2017.

Insurance 90

Insurance Vaccines 90

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Just as mRNA and COVID-19 showed the world that it’s possible to develop vaccines much faster, Del Bourgo explains, AI can help us develop new genomic medicines in a more efficient way.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

AUGUST 4, 2022

The development of an effective COVID-19 vaccine has been universally recognised as our way out of the pandemic, and humanity has seen the tangible impact of vaccines saving countless lives on a massive, global scale. She joined NSF in 2017. appeared first on.

Customer Service 98

Customer Service Vaccines 98

European Pharmaceutical Review

JANUARY 29, 2024

Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed. EMA initiatives for acceleration of development support and evaluation procedures for COVID-19 treatments and vaccines [OBSOLETE].

FDA 111

FDA Vaccines Compounding 111

pharmaphorum

APRIL 16, 2021

Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond. Achievement, meaning commercial performance in the context of sales uptake, as measured by the IQVIA sales audits.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

PQA

NOVEMBER 16, 2023

Here are the PQA Executive Fellowship alumni and where they are today: Laurin Dixon, PharmD, Lead Executive, Medicare Products, Arkansas Blue Cross and Blue Shield (2013-2014 Executive Fellow) Maria Scarlatos Eid, PharmD, CPHQ, Global Professional Relations & Independent Medical Education, Vaccines, Merck (2014-2015 Executive Fellow) Hannah (..)

Vaccines 45

Vaccines 45

ISPE

AUGUST 29, 2022

BioProcess International 15 (September 2017):24–47. The rapid transition between clinical studies to emergency use authorization, and then to the world’s first fully approved vaccine in under two years, highlights the potential of biopharmaceutical companies and health authorities. Published July 2017. Macheras, and K.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines 97

Vaccines Compounding Documentation FDA 97

European Pharmaceutical Review

MAY 15, 2023

Thomas Triomphe, Executive Vice President of Vaccines at Sanofi shared: “The HARMONIE data demonstrate the real-world impact nirsevimab has on paediatric hospitalisations.” Agreed in March 2017, AstraZeneca leads development and manufacturing activities, and Sanofi leads commercialisation activities. percent.

Vaccines 104

Vaccines Hospitals FDA 104

The Checkup by Singlecare

OCTOBER 30, 2023

According to a 2017 database review , no evidence of drug interactions between hormonal contraception and non-rifamycin antibiotics was found. Amoxicillin and oral live vaccines Antibacterial drugs such as amoxicillin can impact the effectiveness of the oral typhoid and cholera vaccines.

Vaccines 105

Vaccines Labelling FDA Dosage 105

pharmaphorum

JANUARY 26, 2022

” “We don’t have an artificial ceiling in our deal size,” he continued, referencing J&J’s $30 billion takeover of Actelion in 2017, but added that “larger deals are much harder to make work, both financially and operationally, and they will always have a higher bar.” Darzalex grew by 31% to $1.6

Vaccines 52

Vaccines 52

pharmaphorum

OCTOBER 12, 2021

Stoffels has been at the helm of the R&D operations at J&J throughout a renaissance of the company’s pharma operations, overseeing the development of more than 25 new medicines across multiple therapeutic areas, including of course J&J’s one-shot COVID-19 vaccine, which won emergency approval in the US in February.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 10, 2020

He was awarded a CBE for patient safety in 2017. He was responsible for the national immunisation programme and led the introduction of many new vaccines. His previous roles include CEO of the King’s Fund, the BBC’s social affairs editor and health correspondent, as well as editor of Nursing Times.

Communication 52

Communication Immunization Vaccines 52

Pharmaceutical Technology

NOVEMBER 7, 2022

AstraZeneca Vaccines and Immune Therapies executive vice-president Iskra Reic said: “Beyfortus is the first single-dose preventative option against the respiratory syncytial virus to gain approval in Europe and is also the first and only preventative option approved for a broad infant population. . “The

Dosage 64

Dosage Immunization Vaccines 64

pharmaphorum

JANUARY 18, 2022

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. 08.30 – 12.30.

Packaging 52

Packaging FDA Documentation Vaccines 52